Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
暂无分享,去创建一个
P. Malfertheiner | A. Gasbarrini | B. Sangro | M. Wildgruber | E. D. De Toni | D. Palmer | J. Valle | C. Sengel | M. Pech | J. Ricke | J. Kupcinskas | B. Basu | M. Seidensticker | H. Klümpen | K. Schütte | O. Öcal | R. Seidensticker | J. Benckert | N. Ben Khaled | T. Berg | Egidijus Morkūnas | Gabija Jurkeviciute | J. Kupčinskas